4//SEC Filing
Cranston Lynda Sarah 4
Accession 0001213900-19-011880
CIK 0001498382other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 4:20 PM ET
Size
5.2 KB
Accession
0001213900-19-011880
Insider Transaction Report
Form 4
Cranston Lynda Sarah
Director
Transactions
- Other
Common Stock
2019-06-28+8→ 300 total(indirect: Held by J.G. Cranston & Associates, Inc.)
Footnotes (2)
- [F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.
- [F2]On May 8, 2019, the issuer effected a 1-for-10 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
Documents
Issuer
DelMar Pharmaceuticals, Inc.
CIK 0001498382
Entity typeother
Related Parties
1- filerCIK 0001633660
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 4:20 PM ET
- Size
- 5.2 KB